HPGC Renmintongtai Pharmaceutical Corporation (SHSE: 600829)
Health Care · Health Care Providers & Services · CN
CN¥9.62
-18.68% today · +15.5% 1Y
HPGC Renmintongtai Pharmaceutical Corporation (SHSE: 600829) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $829.84M and employs 2,735 people.
Over the last twelve months the share price has gained 15.5%, trading between 7.54 and 18.13.
Tweenvest scores HPGC Renmintongtai Pharmaceutical Corporation across four factors: quality 78/100, value 8/100, growth 14/100. Its strongest factor is quality.
600829 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $829.84M
- Revenue (TTM)
- $1.57B
- P/E
- 39.22
- EPS
- 0.25
- Dividend yield
- —
- Beta (5Y)
- 0.04
- 52-week high
- CN¥18.13
- 52-week low
- CN¥7.54
- Avg volume (3M)
- —
- Shares outstanding
- 579.89M
- Employees
- 2,735
- Next earnings
- —
About HPGC Renmintongtai Pharmaceutical Corporation
HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise actively involved in the wholesale and retail distribution of diverse medicinal products across China and internationally. Its extensive product portfolio encompasses traditional Chinese medicines, herbal remedies, chemical preparations, antibiotics, biologics, biochemical drugs, medical equipment, and health-related items. The company also extends its operations to include logistics services, specifically warehousing and distribution. Additionally, it offers comprehensive hospital services covering medical treatment, scientific research, disease prevention, health promotion, rehabilitation, blood purification, and renal disease management. Through its e-commerce platform, HPGC Renmintongtai markets a broad selection of items, including Chinese and Western pharmaceuticals, traditional Chinese herbs, nutritional supplements, medical devices, cosmetics, and everyday necessities. The company maintains a significant retail presence with 319 chain stores located throughout Heilongjiang Province. Established in 1950 and headquartered in Harbin, China, HPGC Renmintongtai Pharmaceutical Corporation operates as a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
- ISIN
- CNE000000G05
- Founded
- 1950
- Listed since
- Feb 24, 1994
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.